Very interesting thread. Especially the debate between Trump In 2024 and Anne Davis. And both claim that the author support's their own view. So let's ask him straight out. Timothy Naegele, what is your opinion on Trump's dinner. Was it wrong? Should it be condemned?
On some level there is something insightful to be said about the impact increased ease of access to information and ease of communication in our current society and the psychology behind the behavior of retail investors. I'm just not certain it's something positive.
I’m very confused by this article. They destroyed Zack’s estimations last year and zack’s have it in cellar because of downward revised EPS? It’s still a 40-45% increase in EPS. Zack’s estimates 20% growth and their forward P/E is 34. Not sure how that’s bearish. But ok.
I keep reading how #Omicron is setting infection records across the US. Yet since we can't get a covid test ANYWHERE, the numbers must be much higher than reported. You can't get added to the official numbers if you can't be tested.
With a half-dozen companies in the psychedelics industry already with announced plans for TBI-related research, some investors may see this R&D niche as crowded.
But with a huge treatment population and an equally huge treatment market to target (estimated to reach $182 billion by 2027), there are more than enough revenue dollars on the table for second- and third-place finishers in this derby to be well-rewarded by the market.
Thanks for sharing: RVV mentioned in article: "Revive Therapeutics (CAN: RVV / US: $RVVTF) plans to seek IND status from the FDA in Q2 2021, for its psilocybin-based research on TBI. With a different (non-psychedelic) drug already in a Phase III clinical trial, Revive has more experience in formal clinical research. But TBI is not the principal focus of its R&D."
What do you mean that people who have recovered from the virus, got it again. How's that possible? I thought once they had anti-bodies to fight off the virus, they would be safe. Were they reinfected by others? Were they not truly recovered? Or can the virus actually come back? Perhaps a person never really gets rid of it.
Latest Comments
Why Are So Many Americans Oblivious To The Pervasive Evil That Is Upon Us, Or Cowed By It?
Not really. You didn't address the dinner at all.
Why Are So Many Americans Oblivious To The Pervasive Evil That Is Upon Us, Or Cowed By It?
Very interesting thread. Especially the debate between Trump In 2024 and Anne Davis. And both claim that the author support's their own view. So let's ask him straight out. Timothy Naegele, what is your opinion on Trump's dinner. Was it wrong? Should it be condemned?
Despite Crashing Stocks And Cryptos, Retail Investors Just Won't Stop Buying All The Dips
On some level there is something insightful to be said about the impact increased ease of access to information and ease of communication in our current society and the psychology behind the behavior of retail investors. I'm just not certain it's something positive.
Bear Of The Day: Align Technology (ALGN)
I’m very confused by this article. They destroyed Zack’s estimations last year and zack’s have it in cellar because of downward revised EPS? It’s still a 40-45% increase in EPS. Zack’s estimates 20% growth and their forward P/E is 34. Not sure how that’s bearish. But ok.
Crypto Analyst Justin Bennett Says Bitcoin Will Break Above $40,000 By Monday
Can't pass 38..
BofA Predicts Tesla EV Market Share In US Will Collapse From 69% To Just 19% By 2024
19% of 3M by 2024 is only 570k sales int he US. You willing to bet against #Tesla only selling ~170k more vehicles in two years? $TSLA
The Omicron Cloud
I keep reading how #Omicron is setting infection records across the US. Yet since we can't get a covid test ANYWHERE, the numbers must be much higher than reported. You can't get added to the official numbers if you can't be tested.
Traumatic Brain Injury: Six Psychedelics Companies Target $120 Billion Market
Bright future for psychedelics TBI R&D
With a half-dozen companies in the psychedelics industry already with announced plans for TBI-related research, some investors may see this R&D niche as crowded.
But with a huge treatment population and an equally huge treatment market to target (estimated to reach $182 billion by 2027), there are more than enough revenue dollars on the table for second- and third-place finishers in this derby to be well-rewarded by the market.
Traumatic Brain Injury: Six Psychedelics Companies Target $120 Billion Market
Thanks for sharing: RVV mentioned in article: "Revive Therapeutics (CAN: RVV / US: $RVVTF) plans to seek IND status from the FDA in Q2 2021, for its psilocybin-based research on TBI. With a different (non-psychedelic) drug already in a Phase III clinical trial, Revive has more experience in formal clinical research. But TBI is not the principal focus of its R&D."
Still Plenty Of Unknowns Around The Virus
What do you mean that people who have recovered from the virus, got it again. How's that possible? I thought once they had anti-bodies to fight off the virus, they would be safe. Were they reinfected by others? Were they not truly recovered? Or can the virus actually come back? Perhaps a person never really gets rid of it.